spacer

GO Term History: Displaying 134 audit records for all terms for the date 2004-02-05

From (YYYY-MM-DD):
To (YYYY-MM-DD):
Period:
Category:
Terms:
Limit:
Date Specification

You can specify an explicit date range that you are interested in by setting the "From" and "To" parameters; this will limit the data displayed to those changes that were recorded within that (inclusive) date range.

Alternatively, you can use the "Period" parameter to view the GO term changes that occurred over a specific number of Day(s), Week(s), Month(s) or Year(s) before a specified date.

If you do not enter a "To" date, then the period will be relative to the current date. If, however, you do specify a "To" value, then the "Period" value will display records in the timeframe up to and including that specified date.

Category

You can use this field to specify what types of term changes you are interested in seeing.

Terms

You can enter a list of GO Terms in this field to limit the changes displayed. Please note that only changes made to directly listed terms will be displayed, not term descendants.

Limit

The default number of records returned is 500, however you can increase or decrease this limit. In order to prevent possible browser problems, the maximum upper limit is 10,000.

Introduction

This page displays the differences recorded in the full Gene Ontology OBO v1.2 file as audited by the UniProt-GOA database during its daily update cycle.
If there is any delay in uploading the current OBO file, the changes displayed and the date recorded for these changes may not correspond to when the changes to the OBO file were committed.

All changes

Timestamp GO ID GO Term Name Action Category Detail
2004-02-05 GO:0019763 immunoglobulin receptor activity Updated TERM immunoglobulin receptor activity
2004-02-05 GO:0043094 cellular metabolic compound salvage Added TERM metabolic compound salvage
2004-02-05 GO:0043095 regulation of GTP cyclohydrolase I activity Added TERM carbon compound salvage
2004-02-05 GO:0043096 purine nucleobase salvage Added TERM purine base salvage
2004-02-05 GO:0043097 pyrimidine nucleoside salvage Added TERM pyrimidine nucleoside salvage
2004-02-05 GO:0043098 purine deoxyribonucleoside salvage Added TERM purine deoxyribonucleoside salvage
2004-02-05 GO:0043095 regulation of GTP cyclohydrolase I activity Added DEFINITION Any process which produces a carbon compound from deriviatives of it, without de novo synthesis.
2004-02-05 GO:0006238 CMP salvage Added DEFINITION Any process that generates CMP, cytidine monophosphate, from deriviatives of it without de novo synthesis.
2004-02-05 GO:0001816 cytokine production Added DEFINITION The synthesis and release of a cytokine following a stimulus, resulting in an increase in its intracellular or extracellular levels.
2004-02-05 GO:0006180 deoxyguanosine salvage Added DEFINITION Any process that generates deoxyguanosine from deriviatives of it, without de novo synthesis.
2004-02-05 GO:0006191 deoxyinosine salvage Added DEFINITION Any process that generates deoxyinosine from deriviatives of it, without de novo synthesis.
2004-02-05 GO:0042352 GDP-L-fucose salvage Updated DEFINITION The formation of GDP-L-fucose from L-fucose, without de novo synthesis. L-fucose is phosphorylated by fucokinase and then converted by fucose-1-phosphate guanylyltransferase (EC:2.7.7.30).
2004-02-05 GO:0006178 guanine salvage Added DEFINITION Any process that generates guanine, 2-amino-6-hydroxypurine, from deriviatives of it without de novo synthesis.
2004-02-05 GO:0006179 guanosine salvage Added DEFINITION Any process that generates guanosine, guanine riboside, from deriviatives of it without de novo synthesis.
2004-02-05 GO:0019764 high affinity Fc receptor activity Added DEFINITION OBSOLETE. (was not defined before being made obsolete).
2004-02-05 GO:0019768 high-affinity IgE receptor activity Added DEFINITION Combining with high affinity with an immunoglobulin of the IgE isotype via the Fc region to initiate a change in cell activity.
2004-02-05 GO:0019771 high-affinity IgG receptor activity Added DEFINITION Combining with high affinity with an immunoglobulin of an IgG isotype via the Fc region to initiate a change in cell activity.
2004-02-05 GO:0019766 IgA receptor activity Added DEFINITION Combining with an immunoglobulin of an IgA isotype via the Fc region to initiate a change in cell activity.
2004-02-05 GO:0019767 IgE receptor activity Added DEFINITION Combining with an immunoglobulin of the IgE isotype via the Fc region to initiate a change in cell activity.
2004-02-05 GO:0019770 IgG receptor activity Added DEFINITION Combining with an immunoglobulin of an IgG isotype via the Fc region to initiate a change in cell activity.
2004-02-05 GO:0001793 IgM receptor activity Added DEFINITION Combining with an immunoglobulin of the IgM isotype via the Fc region to initiate a change in cell activity.
2004-02-05 GO:0016489 immunoglobulin receptor activity Updated DEFINITION OBSOLETE. A transmembrane receptor that binds polymeric IgA and IgM at the basolateral surface of epithelial cells; the complex is then transported across the cell to be secreted at the apical surface; during this process the extracellular domain (secretory component) is cleaved from the transmembrane domain.
2004-02-05 GO:0006190 inosine salvage Added DEFINITION Any process that generates inosine, hypoxanthine riboside, from deriviatives of it without de novo synthesis.
2004-02-05 GO:0019765 low affinity Fc receptor activity Added DEFINITION OBSOLETE. (was not defined before making obsolete).
2004-02-05 GO:0019769 low-affinity IgE receptor activity Added DEFINITION Combining with low affinity with an immunoglobulin of the TgE isotype via the Fc region to initiate a change in cell activity.
2004-02-05 GO:0019772 low-affinity IgG receptor activity Added DEFINITION Combining with low affinity with an immunogloblulin of an IGg isotype via the Fc region to initiate a change in cell activity.
2004-02-05 GO:0043094 cellular metabolic compound salvage Added DEFINITION Any process which produces a useful metabolic compound from deriviatives of it without de novo synthesis.
2004-02-05 GO:0009435 NAD biosynthetic process Added DEFINITION The formation from simpler components of nicotinamide adenine dinucleotide (NAD), a coenzyme present in most living cells and derived from the B vitamin nicotinic acid.
2004-02-05 GO:0019677 NAD catabolic process Added DEFINITION The breakdown into simpler components of nicotinamide adenine dinucleotide (NAD), a coenzyme present in most living cells and derived from the B vitamin nicotinic acid.
2004-02-05 GO:0001792 polymeric immunoglobulin receptor activity Added TERM polymeric immunoglobulin receptor activity
2004-02-05 GO:0001793 IgM receptor activity Added TERM IgM receptor activity
2004-02-05 GO:0001794 type IIa hypersensitivity Added TERM type IIa hypersensitivity
2004-02-05 GO:0001795 type IIb hypersensitivity Added TERM type IIb hypersensitivity
2004-02-05 GO:0001796 regulation of type IIa hypersensitivity Added TERM regulation of type IIa hypersensitivity
2004-02-05 GO:0001797 negative regulation of type IIa hypersensitivity Added TERM negative regulation of type IIa hypersensitivity
2004-02-05 GO:0001798 positive regulation of type IIa hypersensitivity Added TERM positive regulation of type IIa hypersensitivity
2004-02-05 GO:0001799 regulation of type IIb hypersensitivity Added TERM regulation of type IIb hypersensitivity
2004-02-05 GO:0001800 negative regulation of type IIb hypersensitivity Added TERM negative regulation of type IIb hypersensitivity
2004-02-05 GO:0001801 positive regulation of type IIb hypersensitivity Added TERM positive regulation of type IIb hypersensitivity
2004-02-05 GO:0001802 type III hypersensitivity Added TERM type III hypersensitivity
2004-02-05 GO:0001803 regulation of type III hypersensitivity Added TERM regulation of type III hypersensitivity
2004-02-05 GO:0001804 negative regulation of type III hypersensitivity Added TERM negative regulation of type III hypersensitivity
2004-02-05 GO:0001805 positive regulation of type III hypersensitivity Added TERM positive regulation of type III hypersensitivity
2004-02-05 GO:0001806 type IV hypersensitivity Added TERM type IV hypersensitivity
2004-02-05 GO:0001807 regulation of type IV hypersensitivity Added TERM regulation of type IV hypersensitivity
2004-02-05 GO:0001808 negative regulation of type IV hypersensitivity Added TERM negative regulation of type IV hypersensitivity
2004-02-05 GO:0001809 positive regulation of type IV hypersensitivity Added TERM positive regulation of type IV hypersensitivity
2004-02-05 GO:0001810 regulation of type I hypersensitivity Added TERM regulation of type I hypersensitivity
2004-02-05 GO:0001811 negative regulation of type I hypersensitivity Added TERM negative regulation of type I hypersensitivity
2004-02-05 GO:0001812 positive regulation of type I hypersensitivity Added TERM positive regulation of type I hypersensitivity
2004-02-05 GO:0006166 purine ribonucleoside salvage Updated TERM purine ribonucleoside salvage
2004-02-05 GO:0006168 adenine salvage Updated TERM adenine salvage
2004-02-05 GO:0006169 adenosine salvage Updated TERM adenosine salvage
2004-02-05 GO:0006238 CMP salvage Updated TERM cytidine monophosphate salvage
2004-02-05 GO:0006239 dCMP salvage Updated TERM deoxycytidine monophosphate salvage
2004-02-05 GO:0001813 regulation of antibody-dependent cellular cytotoxicity Added TERM regulation of antibody-dependent cellular cytotoxicity
2004-02-05 GO:0001814 negative regulation of antibody-dependent cellular cytotoxicity Added TERM negative regulation of antibody-dependent cellular cytotoxicity
2004-02-05 GO:0001815 positive regulation of antibody-dependent cellular cytotoxicity Added TERM positive regulation of antibody-dependent cellular cytotoxicity
2004-02-05 GO:0001816 cytokine production Added TERM cytokine production
2004-02-05 GO:0001817 regulation of cytokine production Added TERM regulation of cytokine production
2004-02-05 GO:0001818 negative regulation of cytokine production Added TERM negative regulation of cytokine production
2004-02-05 GO:0001819 positive regulation of cytokine production Added TERM positive regulation of cytokine production
2004-02-05 GO:0016068 type I hypersensitivity Updated TERM type I hypersensitivity
2004-02-05 GO:0009435 NAD biosynthetic process Updated TERM NAD biosynthesis
2004-02-05 GO:0019358 nicotinate nucleotide salvage Updated TERM nicotinate nucleotide salvage
2004-02-05 GO:0019365 pyridine nucleotide salvage Updated TERM pyridine nucleotide salvage
2004-02-05 GO:0019509 L-methionine biosynthetic process from methylthioadenosine Updated TERM methionine salvage
2004-02-05 GO:0019674 NAD metabolic process Updated TERM NAD metabolism
2004-02-05 GO:0019675 NAD phosphorylation and dephosphorylation Updated TERM NAD phosphorylation and dephosphorylation
2004-02-05 GO:0019677 NAD catabolic process Updated TERM NAD catabolism
2004-02-05 GO:0009435 NAD biosynthetic process Deleted SYNONYM NAD biosynthesis
2004-02-05 GO:0019677 NAD catabolic process Deleted SYNONYM NAD catabolism
2004-02-05 GO:0001788 antibody-dependent cellular cytotoxicity Added SYNONYM type VI hypersensitivity
2004-02-05 GO:0001795 type IIb hypersensitivity Added SYNONYM type II hypersensitivity
2004-02-05 GO:0001795 type IIb hypersensitivity Added SYNONYM type V hypersensitivity
2004-02-05 GO:0001806 type IV hypersensitivity Added SYNONYM delayed-type hypersensitivity
2004-02-05 GO:0006168 adenine salvage Added SYNONYM adenine salvage pathway
2004-02-05 GO:0006238 CMP salvage Added SYNONYM CMP salvage
2004-02-05 GO:0006239 dCMP salvage Added SYNONYM dCMP salvage
2004-02-05 GO:0009435 NAD biosynthetic process Added SYNONYM nicotinamide adenine dinucleotide biosynthesis
2004-02-05 GO:0016068 type I hypersensitivity Added SYNONYM immediate hypersensitivity response
2004-02-05 GO:0019358 nicotinate nucleotide salvage Added SYNONYM nicotinate nucleotide biosynthesis, salvage pathway
2004-02-05 GO:0019365 pyridine nucleotide salvage Added SYNONYM pyridine nucleotide cycling
2004-02-05 GO:0019509 L-methionine biosynthetic process from methylthioadenosine Added SYNONYM methionine salvage pathway
2004-02-05 GO:0019674 NAD metabolic process Added SYNONYM nicotinamide adenine dinucleotide metabolism
2004-02-05 GO:0019675 NAD phosphorylation and dephosphorylation Added SYNONYM nicotinamide adenine dinucleotide phosphorylation and dephosphorylation
2004-02-05 GO:0019677 NAD catabolic process Added SYNONYM nicotinamide adenine dinucleotide catabolism
2004-02-05 GO:0019763 immunoglobulin receptor activity Added SYNONYM FC receptor activity
2004-02-05 GO:0042351 'de novo' GDP-L-fucose biosynthetic process Added SYNONYM GDP-L-fucose biosynthesis, de novo pathway
2004-02-05 GO:0042352 GDP-L-fucose salvage Added SYNONYM GDP-L-fucose biosynthesis, salvage pathway
2004-02-05 GO:0019674 NAD metabolic process Added DEFINITION The chemical reactions and physical changes involving nicotinamide adenine dinucleotide (NAD), a coenzyme present in most living cells and derived from the B vitamin nicotinic acid.
2004-02-05 GO:0019358 nicotinate nucleotide salvage Updated DEFINITION The formation of nicotinate nucleotide without de novo synthesis.
2004-02-05 GO:0019675 NAD phosphorylation and dephosphorylation Added DEFINITION The addition or removal of a phosphate group from nicotinamide adenine dinucleotide (NAD), a coenzyme present in most living cells and derived from the B vitamin nicotinic acid.
2004-02-05 GO:0006736 NADH biosynthesis Added DEFINITION The formation from simpler components of NADH, the reduced form of nicotinamide adenine dinucleotide (NAD), a coenzyme present in most living cells and derived from the B vitamin nicotinic acid.
2004-02-05 GO:0006737 NADH catabolism Added DEFINITION The breakdown into simpler components of NADH, the reduced form of nicotinamide adenine dinucleotide (NAD), a coenzyme present in most living cells and derived from the B vitamin nicotinic acid.
2004-02-05 GO:0006734 NADH metabolic process Added DEFINITION The chemical reactions and physical changes involving NADH, the reduced form of nicotinamide adenine dinucleotide (NAD), a coenzyme present in most living cells and derived from the B vitamin nicotinic acid.
2004-02-05 GO:0001814 negative regulation of antibody-dependent cellular cytotoxicity Added DEFINITION Any process that stops, prevents, or reduces the rate of antibody-dependent cellular cytotoxicity.
2004-02-05 GO:0001818 negative regulation of cytokine production Added DEFINITION Any process that stops, prevents, or reduces the rate of production of a cytokine.
2004-02-05 GO:0001811 negative regulation of type I hypersensitivity Added DEFINITION Any process that stops, prevents, or reduces the rate of type I hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0001797 negative regulation of type IIa hypersensitivity Added DEFINITION Any process that stops, prevents, or reduces the rate of type IIa hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0001800 negative regulation of type IIb hypersensitivity Added DEFINITION Any process that stops, prevents, or reduces the rate of type IIb hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0001804 negative regulation of type III hypersensitivity Added DEFINITION Any process that stops, prevents, or reduces the rate of type III hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0001808 negative regulation of type IV hypersensitivity Added DEFINITION Any process that stops, prevents, or reduces the rate of type IV hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0001792 polymeric immunoglobulin receptor activity Added DEFINITION Combining with a J-chaine-containing polymeric immunoglobulin of the IGA or IGM isotypes via the Fc region to initiate a change in cell activity.
2004-02-05 GO:0001815 positive regulation of antibody-dependent cellular cytotoxicity Added DEFINITION Any process that activates or increases the rate of antibody-dependent cellular cytotoxicity.
2004-02-05 GO:0001819 positive regulation of cytokine production Added DEFINITION Any process that activates or increases the rate of production of a cytokine.
2004-02-05 GO:0001812 positive regulation of type I hypersensitivity Added DEFINITION Any process that activates or increases the rate of type I hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0001798 positive regulation of type IIa hypersensitivity Added DEFINITION Any process that activates or increases the rate of type IIa hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0001801 positive regulation of type IIb hypersensitivity Added DEFINITION Any process that activates or increases the rate of type IIb hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0042351 'de novo' GDP-L-fucose biosynthetic process Updated TERM 'de novo' GDP-L-fucose biosynthesis
2004-02-05 GO:0042352 GDP-L-fucose salvage Updated TERM GDP-L-fucose salvage
2004-02-05 GO:0001805 positive regulation of type III hypersensitivity Added DEFINITION Any process that activates or increases the rate of type III hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0001809 positive regulation of type IV hypersensitivity Added DEFINITION Any process that activates or increases the rate of type IV hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0043096 purine nucleobase salvage Added DEFINITION Any process that generates purine bases, one of the two classes of nitrogen-containing ring compounds found in DNA and RNA, from deriviatives of them without de novo synthesis.
2004-02-05 GO:0043098 purine deoxyribonucleoside salvage Added DEFINITION Any process which produces a purine deoxyribonucleoside from deriviatives of it, without de novo synthesis.
2004-02-05 GO:0006166 purine ribonucleoside salvage Added DEFINITION Any process which produces a purine nucleoside from deriviatives of it, without de novo synthesis.
2004-02-05 GO:0019363 pyridine nucleotide biosynthetic process Added DEFINITION The formation from simpler components of a pyridine nucleotide, a nucleotide characterized by a pyridine derivative as a nitrogen base.
2004-02-05 GO:0019364 pyridine nucleotide catabolic process Added DEFINITION The breakdown into simpler components of a pyridine nucleotide, a nucleotide characterized by a pyridine derivative as a nitrogen base.
2004-02-05 GO:0019362 pyridine nucleotide metabolic process Added DEFINITION The chemical reactions and physical changes involving a pyridine nucleotide, a nucleotide characterized by a pyridine derivative as a nitrogen base.
2004-02-05 GO:0019365 pyridine nucleotide salvage Added DEFINITION of a pyridine nucleotide, a nucleotide characterized by a pyridine derivative as a nitrogen base.
2004-02-05 GO:0001813 regulation of antibody-dependent cellular cytotoxicity Added DEFINITION Any process that modulates the frequency, rate, or extent of antibody-dependent cellular cytotoxicity.
2004-02-05 GO:0001817 regulation of cytokine production Added DEFINITION Any process that modulates the frequency, rate, or extent of production of a cytokine.
2004-02-05 GO:0001810 regulation of type I hypersensitivity Added DEFINITION Any process that modulates the frequency, rate, or extent of type I hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0001796 regulation of type IIa hypersensitivity Added DEFINITION Any process that modulates the frequency, rate, or extent of type IIa hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0001799 regulation of type IIb hypersensitivity Added DEFINITION Any process that modulates the frequency, rate, or extent of type IIb hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0001803 regulation of type III hypersensitivity Added DEFINITION Any process that modulates the frequency, rate, or extent of type III hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0001807 regulation of type IV hypersensitivity Added DEFINITION Any process that modulates the frequency, rate, or extent of type IV hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0016068 type I hypersensitivity Updated DEFINITION An inflammatory response driven by antigen recognition by antibodies bound to Fc receptors on mast cells, occurring within minutes after exposure of a sensitized individual to the antigen, and leading to the release of a variety of inflammatory mediators such as histamines.
2004-02-05 GO:0001794 type IIa hypersensitivity Added DEFINITION An inflammatory response resulting in cell death mediated by activation of the classical complement pathway or induction of effector cell phagocytosis or cytolysis mechanisms via complement or Fc receptors following the binding of antibodies to cell surface antigens on a target cell.
2004-02-05 GO:0001795 type IIb hypersensitivity Added DEFINITION An inflammatory response resulting from antibody binding of cellular receptors leading to cellular dysfunction.
2004-02-05 GO:0001802 type III hypersensitivity Added DEFINITION An inflammatory response resulting from recognition of immune complexes via complement or Fc receptors on effector cells leading to activation of neutrophils and other leukocytes and damage to bystander tissue.
2004-02-05 GO:0001806 type IV hypersensitivity Added DEFINITION An inflammatory response driven by T-cell recognition of processed soluble or cell-associated antigens leading to cytokine release and leukocyte activation.
2004-02-05 GO:0006168 adenine salvage Added DEFINITION Any process that generates adenine, 6-aminopurine, from deriviatives of it without de novo synthesis.
2004-02-05 GO:0006169 adenosine salvage Added DEFINITION Any process that generates adenosine, adenine riboside, from deriviatives of it without de novo synthesis.

Terms

Timestamp GO ID GO Term Name Action Category Detail
2004-02-05 GO:0019763 immunoglobulin receptor activity Updated TERM immunoglobulin receptor activity
2004-02-05 GO:0043094 cellular metabolic compound salvage Added TERM metabolic compound salvage
2004-02-05 GO:0043095 regulation of GTP cyclohydrolase I activity Added TERM carbon compound salvage
2004-02-05 GO:0043096 purine nucleobase salvage Added TERM purine base salvage
2004-02-05 GO:0043097 pyrimidine nucleoside salvage Added TERM pyrimidine nucleoside salvage
2004-02-05 GO:0043098 purine deoxyribonucleoside salvage Added TERM purine deoxyribonucleoside salvage
2004-02-05 GO:0001792 polymeric immunoglobulin receptor activity Added TERM polymeric immunoglobulin receptor activity
2004-02-05 GO:0001793 IgM receptor activity Added TERM IgM receptor activity
2004-02-05 GO:0001794 type IIa hypersensitivity Added TERM type IIa hypersensitivity
2004-02-05 GO:0001795 type IIb hypersensitivity Added TERM type IIb hypersensitivity
2004-02-05 GO:0001796 regulation of type IIa hypersensitivity Added TERM regulation of type IIa hypersensitivity
2004-02-05 GO:0001797 negative regulation of type IIa hypersensitivity Added TERM negative regulation of type IIa hypersensitivity
2004-02-05 GO:0001798 positive regulation of type IIa hypersensitivity Added TERM positive regulation of type IIa hypersensitivity
2004-02-05 GO:0001799 regulation of type IIb hypersensitivity Added TERM regulation of type IIb hypersensitivity
2004-02-05 GO:0001800 negative regulation of type IIb hypersensitivity Added TERM negative regulation of type IIb hypersensitivity
2004-02-05 GO:0001801 positive regulation of type IIb hypersensitivity Added TERM positive regulation of type IIb hypersensitivity
2004-02-05 GO:0001802 type III hypersensitivity Added TERM type III hypersensitivity
2004-02-05 GO:0001803 regulation of type III hypersensitivity Added TERM regulation of type III hypersensitivity
2004-02-05 GO:0001804 negative regulation of type III hypersensitivity Added TERM negative regulation of type III hypersensitivity
2004-02-05 GO:0001805 positive regulation of type III hypersensitivity Added TERM positive regulation of type III hypersensitivity
2004-02-05 GO:0001806 type IV hypersensitivity Added TERM type IV hypersensitivity
2004-02-05 GO:0001807 regulation of type IV hypersensitivity Added TERM regulation of type IV hypersensitivity
2004-02-05 GO:0001808 negative regulation of type IV hypersensitivity Added TERM negative regulation of type IV hypersensitivity
2004-02-05 GO:0001809 positive regulation of type IV hypersensitivity Added TERM positive regulation of type IV hypersensitivity
2004-02-05 GO:0001810 regulation of type I hypersensitivity Added TERM regulation of type I hypersensitivity
2004-02-05 GO:0001811 negative regulation of type I hypersensitivity Added TERM negative regulation of type I hypersensitivity
2004-02-05 GO:0001812 positive regulation of type I hypersensitivity Added TERM positive regulation of type I hypersensitivity
2004-02-05 GO:0006166 purine ribonucleoside salvage Updated TERM purine ribonucleoside salvage
2004-02-05 GO:0006168 adenine salvage Updated TERM adenine salvage
2004-02-05 GO:0006169 adenosine salvage Updated TERM adenosine salvage
2004-02-05 GO:0006238 CMP salvage Updated TERM cytidine monophosphate salvage
2004-02-05 GO:0006239 dCMP salvage Updated TERM deoxycytidine monophosphate salvage
2004-02-05 GO:0001813 regulation of antibody-dependent cellular cytotoxicity Added TERM regulation of antibody-dependent cellular cytotoxicity
2004-02-05 GO:0001814 negative regulation of antibody-dependent cellular cytotoxicity Added TERM negative regulation of antibody-dependent cellular cytotoxicity
2004-02-05 GO:0001815 positive regulation of antibody-dependent cellular cytotoxicity Added TERM positive regulation of antibody-dependent cellular cytotoxicity
2004-02-05 GO:0001816 cytokine production Added TERM cytokine production
2004-02-05 GO:0001817 regulation of cytokine production Added TERM regulation of cytokine production
2004-02-05 GO:0001818 negative regulation of cytokine production Added TERM negative regulation of cytokine production
2004-02-05 GO:0001819 positive regulation of cytokine production Added TERM positive regulation of cytokine production
2004-02-05 GO:0016068 type I hypersensitivity Updated TERM type I hypersensitivity
2004-02-05 GO:0009435 NAD biosynthetic process Updated TERM NAD biosynthesis
2004-02-05 GO:0019358 nicotinate nucleotide salvage Updated TERM nicotinate nucleotide salvage
2004-02-05 GO:0019365 pyridine nucleotide salvage Updated TERM pyridine nucleotide salvage
2004-02-05 GO:0019509 L-methionine biosynthetic process from methylthioadenosine Updated TERM methionine salvage
2004-02-05 GO:0019674 NAD metabolic process Updated TERM NAD metabolism
2004-02-05 GO:0019675 NAD phosphorylation and dephosphorylation Updated TERM NAD phosphorylation and dephosphorylation
2004-02-05 GO:0019677 NAD catabolic process Updated TERM NAD catabolism
2004-02-05 GO:0042351 'de novo' GDP-L-fucose biosynthetic process Updated TERM 'de novo' GDP-L-fucose biosynthesis
2004-02-05 GO:0042352 GDP-L-fucose salvage Updated TERM GDP-L-fucose salvage

Definition/synonyms

Timestamp GO ID GO Term Name Action Category Detail
2004-02-05 GO:0043095 regulation of GTP cyclohydrolase I activity Added DEFINITION Any process which produces a carbon compound from deriviatives of it, without de novo synthesis.
2004-02-05 GO:0006238 CMP salvage Added DEFINITION Any process that generates CMP, cytidine monophosphate, from deriviatives of it without de novo synthesis.
2004-02-05 GO:0001816 cytokine production Added DEFINITION The synthesis and release of a cytokine following a stimulus, resulting in an increase in its intracellular or extracellular levels.
2004-02-05 GO:0006180 deoxyguanosine salvage Added DEFINITION Any process that generates deoxyguanosine from deriviatives of it, without de novo synthesis.
2004-02-05 GO:0006191 deoxyinosine salvage Added DEFINITION Any process that generates deoxyinosine from deriviatives of it, without de novo synthesis.
2004-02-05 GO:0042352 GDP-L-fucose salvage Updated DEFINITION The formation of GDP-L-fucose from L-fucose, without de novo synthesis. L-fucose is phosphorylated by fucokinase and then converted by fucose-1-phosphate guanylyltransferase (EC:2.7.7.30).
2004-02-05 GO:0006178 guanine salvage Added DEFINITION Any process that generates guanine, 2-amino-6-hydroxypurine, from deriviatives of it without de novo synthesis.
2004-02-05 GO:0006179 guanosine salvage Added DEFINITION Any process that generates guanosine, guanine riboside, from deriviatives of it without de novo synthesis.
2004-02-05 GO:0019764 high affinity Fc receptor activity Added DEFINITION OBSOLETE. (was not defined before being made obsolete).
2004-02-05 GO:0019768 high-affinity IgE receptor activity Added DEFINITION Combining with high affinity with an immunoglobulin of the IgE isotype via the Fc region to initiate a change in cell activity.
2004-02-05 GO:0019771 high-affinity IgG receptor activity Added DEFINITION Combining with high affinity with an immunoglobulin of an IgG isotype via the Fc region to initiate a change in cell activity.
2004-02-05 GO:0019766 IgA receptor activity Added DEFINITION Combining with an immunoglobulin of an IgA isotype via the Fc region to initiate a change in cell activity.
2004-02-05 GO:0019767 IgE receptor activity Added DEFINITION Combining with an immunoglobulin of the IgE isotype via the Fc region to initiate a change in cell activity.
2004-02-05 GO:0019770 IgG receptor activity Added DEFINITION Combining with an immunoglobulin of an IgG isotype via the Fc region to initiate a change in cell activity.
2004-02-05 GO:0001793 IgM receptor activity Added DEFINITION Combining with an immunoglobulin of the IgM isotype via the Fc region to initiate a change in cell activity.
2004-02-05 GO:0016489 immunoglobulin receptor activity Updated DEFINITION OBSOLETE. A transmembrane receptor that binds polymeric IgA and IgM at the basolateral surface of epithelial cells; the complex is then transported across the cell to be secreted at the apical surface; during this process the extracellular domain (secretory component) is cleaved from the transmembrane domain.
2004-02-05 GO:0006190 inosine salvage Added DEFINITION Any process that generates inosine, hypoxanthine riboside, from deriviatives of it without de novo synthesis.
2004-02-05 GO:0019765 low affinity Fc receptor activity Added DEFINITION OBSOLETE. (was not defined before making obsolete).
2004-02-05 GO:0019769 low-affinity IgE receptor activity Added DEFINITION Combining with low affinity with an immunoglobulin of the TgE isotype via the Fc region to initiate a change in cell activity.
2004-02-05 GO:0019772 low-affinity IgG receptor activity Added DEFINITION Combining with low affinity with an immunogloblulin of an IGg isotype via the Fc region to initiate a change in cell activity.
2004-02-05 GO:0043094 cellular metabolic compound salvage Added DEFINITION Any process which produces a useful metabolic compound from deriviatives of it without de novo synthesis.
2004-02-05 GO:0009435 NAD biosynthetic process Added DEFINITION The formation from simpler components of nicotinamide adenine dinucleotide (NAD), a coenzyme present in most living cells and derived from the B vitamin nicotinic acid.
2004-02-05 GO:0019677 NAD catabolic process Added DEFINITION The breakdown into simpler components of nicotinamide adenine dinucleotide (NAD), a coenzyme present in most living cells and derived from the B vitamin nicotinic acid.
2004-02-05 GO:0009435 NAD biosynthetic process Deleted SYNONYM NAD biosynthesis
2004-02-05 GO:0019677 NAD catabolic process Deleted SYNONYM NAD catabolism
2004-02-05 GO:0001788 antibody-dependent cellular cytotoxicity Added SYNONYM type VI hypersensitivity
2004-02-05 GO:0001795 type IIb hypersensitivity Added SYNONYM type II hypersensitivity
2004-02-05 GO:0001795 type IIb hypersensitivity Added SYNONYM type V hypersensitivity
2004-02-05 GO:0001806 type IV hypersensitivity Added SYNONYM delayed-type hypersensitivity
2004-02-05 GO:0006168 adenine salvage Added SYNONYM adenine salvage pathway
2004-02-05 GO:0006238 CMP salvage Added SYNONYM CMP salvage
2004-02-05 GO:0006239 dCMP salvage Added SYNONYM dCMP salvage
2004-02-05 GO:0009435 NAD biosynthetic process Added SYNONYM nicotinamide adenine dinucleotide biosynthesis
2004-02-05 GO:0016068 type I hypersensitivity Added SYNONYM immediate hypersensitivity response
2004-02-05 GO:0019358 nicotinate nucleotide salvage Added SYNONYM nicotinate nucleotide biosynthesis, salvage pathway
2004-02-05 GO:0019365 pyridine nucleotide salvage Added SYNONYM pyridine nucleotide cycling
2004-02-05 GO:0019509 L-methionine biosynthetic process from methylthioadenosine Added SYNONYM methionine salvage pathway
2004-02-05 GO:0019674 NAD metabolic process Added SYNONYM nicotinamide adenine dinucleotide metabolism
2004-02-05 GO:0019675 NAD phosphorylation and dephosphorylation Added SYNONYM nicotinamide adenine dinucleotide phosphorylation and dephosphorylation
2004-02-05 GO:0019677 NAD catabolic process Added SYNONYM nicotinamide adenine dinucleotide catabolism
2004-02-05 GO:0019763 immunoglobulin receptor activity Added SYNONYM FC receptor activity
2004-02-05 GO:0042351 'de novo' GDP-L-fucose biosynthetic process Added SYNONYM GDP-L-fucose biosynthesis, de novo pathway
2004-02-05 GO:0042352 GDP-L-fucose salvage Added SYNONYM GDP-L-fucose biosynthesis, salvage pathway
2004-02-05 GO:0019674 NAD metabolic process Added DEFINITION The chemical reactions and physical changes involving nicotinamide adenine dinucleotide (NAD), a coenzyme present in most living cells and derived from the B vitamin nicotinic acid.
2004-02-05 GO:0019358 nicotinate nucleotide salvage Updated DEFINITION The formation of nicotinate nucleotide without de novo synthesis.
2004-02-05 GO:0019675 NAD phosphorylation and dephosphorylation Added DEFINITION The addition or removal of a phosphate group from nicotinamide adenine dinucleotide (NAD), a coenzyme present in most living cells and derived from the B vitamin nicotinic acid.
2004-02-05 GO:0006736 NADH biosynthesis Added DEFINITION The formation from simpler components of NADH, the reduced form of nicotinamide adenine dinucleotide (NAD), a coenzyme present in most living cells and derived from the B vitamin nicotinic acid.
2004-02-05 GO:0006737 NADH catabolism Added DEFINITION The breakdown into simpler components of NADH, the reduced form of nicotinamide adenine dinucleotide (NAD), a coenzyme present in most living cells and derived from the B vitamin nicotinic acid.
2004-02-05 GO:0006734 NADH metabolic process Added DEFINITION The chemical reactions and physical changes involving NADH, the reduced form of nicotinamide adenine dinucleotide (NAD), a coenzyme present in most living cells and derived from the B vitamin nicotinic acid.
2004-02-05 GO:0001814 negative regulation of antibody-dependent cellular cytotoxicity Added DEFINITION Any process that stops, prevents, or reduces the rate of antibody-dependent cellular cytotoxicity.
2004-02-05 GO:0001818 negative regulation of cytokine production Added DEFINITION Any process that stops, prevents, or reduces the rate of production of a cytokine.
2004-02-05 GO:0001811 negative regulation of type I hypersensitivity Added DEFINITION Any process that stops, prevents, or reduces the rate of type I hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0001797 negative regulation of type IIa hypersensitivity Added DEFINITION Any process that stops, prevents, or reduces the rate of type IIa hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0001800 negative regulation of type IIb hypersensitivity Added DEFINITION Any process that stops, prevents, or reduces the rate of type IIb hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0001804 negative regulation of type III hypersensitivity Added DEFINITION Any process that stops, prevents, or reduces the rate of type III hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0001808 negative regulation of type IV hypersensitivity Added DEFINITION Any process that stops, prevents, or reduces the rate of type IV hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0001792 polymeric immunoglobulin receptor activity Added DEFINITION Combining with a J-chaine-containing polymeric immunoglobulin of the IGA or IGM isotypes via the Fc region to initiate a change in cell activity.
2004-02-05 GO:0001815 positive regulation of antibody-dependent cellular cytotoxicity Added DEFINITION Any process that activates or increases the rate of antibody-dependent cellular cytotoxicity.
2004-02-05 GO:0001819 positive regulation of cytokine production Added DEFINITION Any process that activates or increases the rate of production of a cytokine.
2004-02-05 GO:0001812 positive regulation of type I hypersensitivity Added DEFINITION Any process that activates or increases the rate of type I hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0001798 positive regulation of type IIa hypersensitivity Added DEFINITION Any process that activates or increases the rate of type IIa hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0001801 positive regulation of type IIb hypersensitivity Added DEFINITION Any process that activates or increases the rate of type IIb hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0001805 positive regulation of type III hypersensitivity Added DEFINITION Any process that activates or increases the rate of type III hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0001809 positive regulation of type IV hypersensitivity Added DEFINITION Any process that activates or increases the rate of type IV hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0043096 purine nucleobase salvage Added DEFINITION Any process that generates purine bases, one of the two classes of nitrogen-containing ring compounds found in DNA and RNA, from deriviatives of them without de novo synthesis.
2004-02-05 GO:0043098 purine deoxyribonucleoside salvage Added DEFINITION Any process which produces a purine deoxyribonucleoside from deriviatives of it, without de novo synthesis.
2004-02-05 GO:0006166 purine ribonucleoside salvage Added DEFINITION Any process which produces a purine nucleoside from deriviatives of it, without de novo synthesis.
2004-02-05 GO:0019363 pyridine nucleotide biosynthetic process Added DEFINITION The formation from simpler components of a pyridine nucleotide, a nucleotide characterized by a pyridine derivative as a nitrogen base.
2004-02-05 GO:0019364 pyridine nucleotide catabolic process Added DEFINITION The breakdown into simpler components of a pyridine nucleotide, a nucleotide characterized by a pyridine derivative as a nitrogen base.
2004-02-05 GO:0019362 pyridine nucleotide metabolic process Added DEFINITION The chemical reactions and physical changes involving a pyridine nucleotide, a nucleotide characterized by a pyridine derivative as a nitrogen base.
2004-02-05 GO:0019365 pyridine nucleotide salvage Added DEFINITION of a pyridine nucleotide, a nucleotide characterized by a pyridine derivative as a nitrogen base.
2004-02-05 GO:0001813 regulation of antibody-dependent cellular cytotoxicity Added DEFINITION Any process that modulates the frequency, rate, or extent of antibody-dependent cellular cytotoxicity.
2004-02-05 GO:0001817 regulation of cytokine production Added DEFINITION Any process that modulates the frequency, rate, or extent of production of a cytokine.
2004-02-05 GO:0001810 regulation of type I hypersensitivity Added DEFINITION Any process that modulates the frequency, rate, or extent of type I hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0001796 regulation of type IIa hypersensitivity Added DEFINITION Any process that modulates the frequency, rate, or extent of type IIa hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0001799 regulation of type IIb hypersensitivity Added DEFINITION Any process that modulates the frequency, rate, or extent of type IIb hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0001803 regulation of type III hypersensitivity Added DEFINITION Any process that modulates the frequency, rate, or extent of type III hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0001807 regulation of type IV hypersensitivity Added DEFINITION Any process that modulates the frequency, rate, or extent of type IV hypersensitivity, a type of inflammatory response.
2004-02-05 GO:0016068 type I hypersensitivity Updated DEFINITION An inflammatory response driven by antigen recognition by antibodies bound to Fc receptors on mast cells, occurring within minutes after exposure of a sensitized individual to the antigen, and leading to the release of a variety of inflammatory mediators such as histamines.
2004-02-05 GO:0001794 type IIa hypersensitivity Added DEFINITION An inflammatory response resulting in cell death mediated by activation of the classical complement pathway or induction of effector cell phagocytosis or cytolysis mechanisms via complement or Fc receptors following the binding of antibodies to cell surface antigens on a target cell.
2004-02-05 GO:0001795 type IIb hypersensitivity Added DEFINITION An inflammatory response resulting from antibody binding of cellular receptors leading to cellular dysfunction.
2004-02-05 GO:0001802 type III hypersensitivity Added DEFINITION An inflammatory response resulting from recognition of immune complexes via complement or Fc receptors on effector cells leading to activation of neutrophils and other leukocytes and damage to bystander tissue.
2004-02-05 GO:0001806 type IV hypersensitivity Added DEFINITION An inflammatory response driven by T-cell recognition of processed soluble or cell-associated antigens leading to cytokine release and leukocyte activation.
2004-02-05 GO:0006168 adenine salvage Added DEFINITION Any process that generates adenine, 6-aminopurine, from deriviatives of it without de novo synthesis.
2004-02-05 GO:0006169 adenosine salvage Added DEFINITION Any process that generates adenosine, adenine riboside, from deriviatives of it without de novo synthesis.
spacer
Please send comments, suggestions or bug reports to goa@ebi.ac.uk. Click here for details of how to cite UniProt-GOA and QuickGO.
124ms